secwatch / observer
8-K filed July 21, 2021, 7:59 PM ET ticker TEVA CIK 0000818686
leadership confidence high sentiment neutral materiality 0.50

Teva announces executive reshuffle; North America Commercial head replaced, two promotions

TEVA PHARMACEUTICAL INDUSTRIES LTD

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brendan O’Grady

Executive Vice President – North America Commercial
TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTD
Effective
2021-08-15
Filed
July 21, 2021, 7:59 PM ET
Brendan O’Grady, Executive Vice President – North America Commercial, has submitted his resignation from Teva, effective August 15, 2021, in order to pursue other career opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brendan O’Grady resigned as Executive Vice President – North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD.

Action
resigned
Role
Executive Vice President – North America Commercial
Exact text from the filing
Brendan O’Grady, Executive Vice President – North America Commercial, has submitted his resignation from Teva, effective August 15, 2021, in order to pursue other career opportunities.
View on SEC.gov

TEVA PHARMACEUTICAL INDUSTRIES LTD filing history →

Source: SEC EDGAR
accession 0001157523-21-000890
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.